You have 9 free searches left this month | for more free features.

Low Molecular weight heparin

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Associated Thrombosis for Rivaroxaban - United States

Completed
  • Treatment of Venous Thromboembolism in Cancer Patients
  • Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +2 more
  • Multiple Locations, Connecticut
    Many Locations
May 18, 2022

Acute Coronary Syndrome Trial (A-Phase: tirofiban; Z-Phase simvastatin, Duration of Treatment: A-Phase: minimum suggested 48

Completed
  • Acute Coronary Syndrome
  • A-Phase: tirofiban; Z-Phase simvastatin
  • +4 more
  • (no location specified)
Feb 7, 2022

COVID, Thrombosis, Pulmonary Embolism Trial in France (Enoxaparin)

Completed
  • COVID
  • +3 more
  • Amiens, France
  • +16 more
Dec 17, 2021

Aspirin Thromboprophylaxis After First-line Total Hip and Knee

Recruiting
  • Hip and Knee Prosthesis Implantation
    • Strasbourg, France
      Service de Chirurgie Orthopédique Pédiatrique - Hôpitaux Univers
    Nov 23, 2021

    COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml

    Recruiting
    • COVID-19 Severe Respiratory Failure
    • Alexandroupolis, Evros, Greece
      University Hospital of Alexandroupolis
    Mar 11, 2022

    Pregnancy, High Risk, Anticoagulants Trial in Orange (Lovenox)

    Recruiting
    • Pregnancy, High Risk
    • Anticoagulants
    • Orange, California
      University of California Irvine
    Apr 22, 2021

    Adenomyosis, Assisted Reproductive Technology Trial in Nanjing (Low molecular weight heparin)

    Active, not recruiting
    • Adenomyosis
    • Assisted Reproductive Technology
    • Low molecular weight heparin
    • Nanjing, Jiangsu, China
      Reproductive Medicine Center, The affiliated Drum Towel Hospital
    Feb 3, 2021

    Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular

    Recruiting
    • Cirrhosis
    • +3 more
    • Apixaban 2.5 MG
    • +2 more
    • Yangzhou, Jiangsu, China
      Clinical Medical College, Yangzhou University
    Apr 30, 2022

    Cardiovascular Diseases, COVID-19 Trial in Boston (Enoxaparin)

    Recruiting
    • Cardiovascular Diseases
    • COVID-19
    • Boston, Massachusetts
      Abdurahman Khalil
    Feb 4, 2022

    Pulmonary Embolism, Thoracic Surgery Trial in Shanghai (Chemoprophylaxis with Low Molecular Weight Heparin (LMWH))

    Completed
    • Pulmonary Embolism
    • Thoracic Surgery
    • Chemoprophylaxis with Low Molecular Weight Heparin (LMWH)
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 5, 2021

    COVID-19 Trial in Melbourne, Brasschaat, Johannesburg (Enoxaparin)

    Terminated
    • COVID-19
    • Melbourne, Australia
    • +2 more
    Apr 26, 2022

    Severe Fever With Thrombocytopenia Syndrome Trial in China (Methylprednisolone, intravenous immunoglobulin, Tocilizumab)

    Recruiting
    • Severe Fever With Thrombocytopenia Syndrome
    • Guangshui, Hubei, China
    • +9 more
    Oct 31, 2022

    LMWH Compliance in Pregnancy

    Recruiting
    • Venous Thromboembolism
    • Antenatal Deep Vein Thrombosis
    • Smart sharps bin - collects data on compliance
    • Cork, Ireland
      Cork University Maternity Hospital
    Sep 23, 2021

    Pneumonia, Viral, Cytokine Storm Trial in Madrid, Valencia (radiation, device, drug)

    Suspended
    • Pneumonia, Viral
    • Cytokine Storm
    • Ultra-Low-dose radiotherapy
    • +8 more
    • Madrid, Spain
    • +1 more
    Mar 14, 2022

    Thrombophlebitis Trial in Bologna, Piacenza (LMWH parnaparin subcutaneously)

    Completed
    • Thrombophlebitis
    • LMWH parnaparin subcutaneously
    • Bologna, BO, Italy
    • +1 more
    Mar 18, 2021

    Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

    Recruiting
    • Cirrhosis
    • +3 more
    • Yangzhou, Jiangsu, China
      Clinical Medical College of Yangzhou University
    Mar 19, 2022

    Covid19 Trial in Austin (Enoxaparin, Rivaroxaban)

    Completed
    • Covid19
    • Austin, Texas
      St. David's Medical Center
    Jun 28, 2021

    Rhegmatogenous Retinal Detachment, High-risk for Proliferative Vitreoretinopathy (PVR) Trial in Germany (5-fluorouracil and low

    Completed
    • Rhegmatogenous Retinal Detachment
    • High-risk for Proliferative Vitreoretinopathy (PVR)
    • 5-fluorouracil and low molecular weight heparin
    • Placebo
    • Freiburg, BW, Germany
    • +12 more
    Apr 4, 2022

    COVID-19 Pneumonia Trial in Jinan (Bevacizumab)

    Recruiting
    • COVID-19 Pneumonia
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    Jan 13, 2023

    Esophageal Tumors, Thrombosis, Thromboembolism Trial in Aarhus N (Fragmin 5000 UNT in 0.2 ML Prefilled Syringe)

    Recruiting
    • Esophageal Neoplasms
    • +2 more
    • Fragmin 5000 UNT in 0.2 ML Prefilled Syringe
    • Aarhus N, Denmark
      Thrombosis and Haemostasis Research Unit, Department for Clinica
    Sep 23, 2021

    Hepatic Artery Thrombosis, Liver Transplant; Complications, Pediatric Disease Trial in Shanghai (Ticagrelor Oral Tablet

    Not yet recruiting
    • Hepatic Artery Thrombosis
    • +2 more
    • Ticagrelor Oral Tablet [Brilinta]
    • Low molecular weight heparin
    • Shanghai, China
      Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
    Jun 23, 2021

    Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)

    Completed
    • Sars-CoV2
    • COVID
    • Newark, New Jersey
    • +5 more
    Nov 17, 2021

    Subsegmental Pulmonary Embolism Nos Trial in Redhill (No treatment, Warfarin, direct oral anticoagulants)

    Recruiting
    • Subsegmental Pulmonary Embolism Nos
    • No treatment
    • +3 more
    • Redhill, United Kingdom
      Surrey & Sussex Healthcare NHS Trust
    Sep 28, 2021

    Coronavirus Disease (COVID)19 Trial in Cairo (low-molecular-weight heparin)

    Unknown status
    • Coronavirus Disease (COVID)19
    • low-molecular-weight heparin
    • Cairo, Non-US, Egypt
      Faculty of Medicine Ain Shams University Research Institute- Cli
    Oct 10, 2020

    Pulmonary Embolism, COVID Trial in Los Angeles (TNKase, Placebo, Enoxaparin)

    Terminated
    • Pulmonary Embolism
    • COVID
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Oct 20, 2021